Atrium Therapeutics, Inc.
NASDAQ:RNABiotechnology
Healthcare
$6.64 +1.28%
+$0.16 today
- Market cap
- $143.23M
- Beta
- 0.42
- P/E (TTM)
- -3.3
- EPS (TTM)
- -$3.78
52W Low $11.40High $16.77
Volume 0.22M
Average 0.35M
RNA Total Debt
Short-term and long-term borrowings combined.
Atrium Therapeutics, Inc.NASDAQ: RNA
Total Debt · Q1 FY2026 · quarter ended Mar 2026
Total debt of $2.68M in Q1 FY2026
Q1 FY2026 total debt was $2.68M.
Context
- Total debt amounted to 0.9% of total assets at the end of Q1 FY2026.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Debt history
USD · from the balance sheet
- Latest · FY2025
- 3.67M USD
- Year-over-year change
- —
| Period | Period end | Total Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.67M | — |
Sign in to see up to ten periods of history.Sign in
Total Debt vs competitors
How RNA compares with its peers on the latest reported figures
No competitor Total Debt figures are available to compare.
Balance Sheet
USD
Atrium Therapeutics, Inc.
NASDAQ:RNA
Intrinsic Alpha fair value
Locked
Current Price
$6.64
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.